MICHELLE PICCONI: Open Payments
NPI 1841776291 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 15 payments from 10 companies in 2025. Trend: 2023 $60 · 2024 $272 · 2025 $720
Food & beverage: $627Education: $93
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $248 |
| GlaxoSmithKline, LLC. | 3 | $195 |
| Legend Biotech USA Inc. | 1 | $113 |
| GENZYME CORPORATION | 1 | $31 |
| Syndax Pharmaceuticals, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Apellis Pharmaceuticals, Inc. | 1 | $21 |
| SOBI, INC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: BLENREP, Niktimvo, CARVYKTI, SARCLISA, REVUFORJ, Vanflyta, MONJUVI, ZERBAXA.
Industry payments across MN — which companies pay providers there.
